Cambridge Investment Research Advisors Inc. lifted its holdings in Relx PLC (NYSE:RELX) by 5.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 165,197 shares of the technology company’s stock after purchasing an additional 8,345 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Relx were worth $3,458,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Bank of America Corp DE lifted its position in Relx by 3.7% in the second quarter. Bank of America Corp DE now owns 3,062,325 shares of the technology company’s stock worth $66,575,000 after buying an additional 108,304 shares during the last quarter. Renaissance Technologies LLC lifted its position in Relx by 8.9% in the second quarter. Renaissance Technologies LLC now owns 2,049,928 shares of the technology company’s stock worth $44,565,000 after buying an additional 168,300 shares during the last quarter. Northern Trust Corp lifted its position in Relx by 3.4% in the second quarter. Northern Trust Corp now owns 1,405,497 shares of the technology company’s stock worth $30,556,000 after buying an additional 45,872 shares during the last quarter. Wells Fargo & Company MN lifted its position in Relx by 24.4% in the third quarter. Wells Fargo & Company MN now owns 1,351,271 shares of the technology company’s stock worth $28,283,000 after buying an additional 264,858 shares during the last quarter. Finally, Aperio Group LLC lifted its position in Relx by 30.1% in the third quarter. Aperio Group LLC now owns 1,225,114 shares of the technology company’s stock worth $25,642,000 after buying an additional 283,420 shares during the last quarter. 3.11% of the stock is owned by hedge funds and other institutional investors.

A number of analysts recently issued reports on RELX shares. Barclays upgraded Relx from an “equal weight” rating to an “overweight” rating in a research report on Monday, September 24th. Zacks Investment Research downgraded Relx from a “hold” rating to a “sell” rating in a research report on Wednesday, July 18th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $23.00.

Shares of RELX opened at $20.40 on Wednesday. The firm has a market capitalization of $21.44 billion, a P/E ratio of 19.81 and a beta of 0.56. Relx PLC has a 52-week low of $19.23 and a 52-week high of $24.03. The company has a quick ratio of 0.37, a current ratio of 0.41 and a debt-to-equity ratio of 2.39.

COPYRIGHT VIOLATION NOTICE: “Cambridge Investment Research Advisors Inc. Acquires 8,345 Shares of Relx PLC (RELX)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2018/11/14/cambridge-investment-research-advisors-inc-acquires-8345-shares-of-relx-plc-relx.html.

Relx Company Profile

RELX PLC provides information and analytics for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals.

Read More: Asset Allocation and Your Retirement

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx PLC (NYSE:RELX).

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.